Liquid biopsy enabled rapid and accurate molecular diagnosis of EBV-positive Burkitt's lymphoma in more than 200 children and young adults in Tanzania and Uganda. The study focused on the clinical validation of this test in endemic areas. The test detects EBV-positive Burkitt's lymphoma through a liquid biopsy. The results confirm its reliability in practice. The article was published in Nature Medicine on March 19, 2026 with doi:10.1038/s41591-026-04291-z. This approach brings the advantage of rapid diagnosis in areas with a high incidence of the disease.